Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 9,811 shares at $62.89 ($617K) on 2018-01-30, disclosed to the SEC on 2018-02-01.
Scheduled sale ($617k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.83 | 945 | $59K | 9.6% |
| 2 | $62.83 | 3,506 | $220K | 35.7% |
| 3 | $62.84 | 662 | $42K | 6.7% |
| 4 | $62.85 | 1,198 | $75K | 12.2% |
| 5 | $62.85 | 1,400 | $88K | 14.3% |
| 6 | $62.86 | 700 |
| $44K |
| 7.1% |
| 7 | $62.86 | 600 | $38K | 6.1% |
| 8 | $62.87 | 600 | $38K | 6.1% |
| 9 | $62.89 | 200 | $13K | 2.0% |
| Total | $62.84 avg | 9,811 | $617K | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |